{"@context":"https://schema.org","@type":"Corporation","name":"GLAND PHARMA LIMITED","alternateName":"GLAND","tickerSymbol":"GLAND","identifier":"GLAND","description":"GLAND PHARMA LIMITED (GLAND) financials: Market Cap ₹50,219Cr., Price ₹3,043, P/E 35.6, ROE 12.8%. Jun 2026: sales ₹1,287 Cr, net profit ₹364 Cr. Quarterly res…","url":"https://fincrux.org/companies/GLAND","sameAs":["https://fincrux.org/companies/GLAND"],"dateModified":"2026-10-19T05:27:23.537307","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹50,219Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹3,043"},{"@type":"PropertyValue","name":"Stock P/E","value":"35.6"},{"@type":"PropertyValue","name":"ROE","value":"12.8%"},{"@type":"PropertyValue","name":"ROCE","value":"17.4%"},{"@type":"PropertyValue","name":"Book Value","value":"₹656"},{"@type":"PropertyValue","name":"Dividend Yield","value":"0.66%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹3,171/1,574"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/GLAND#webpage","name":"GLAND PHARMA LIMITED (GLAND) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/GLAND","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/GLAND"}}